R01 CA112199/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	1
2007	1
2008	3
2009	4
2010	2
2011	2
2012	1
2024	0

1

Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpected.

Stoeltzing O, Meric-Bernstam F, Ellis LM. Stoeltzing O, et al. Cancer Cell. 2006 Aug;10(2):89-91. doi: 10.1016/j.ccr.2006.07.013. Cancer Cell. 2006. PMID: 16904605 Free article. Review.

2

RNA-binding specificity of Y-box protein 1.

Dong J, Akcakanat A, Stivers DN, Zhang J, Kim D, Meric-Bernstam F. Dong J, et al. RNA Biol. 2009 Jan-Mar;6(1):59-64. doi: 10.4161/rna.6.1.7458. Epub 2009 Jan 19. RNA Biol. 2009. PMID: 19098458 Free PMC article.

3

Targeting the mTOR signaling network for cancer therapy.

Meric-Bernstam F, Gonzalez-Angulo AM. Meric-Bernstam F, et al. J Clin Oncol. 2009 May 1;27(13):2278-87. doi: 10.1200/JCO.2008.20.0766. Epub 2009 Mar 30. J Clin Oncol. 2009. PMID: 19332717 Free PMC article. Review.

4

Rapamycin regulates the phosphorylation of rictor.

Akcakanat A, Singh G, Hung MC, Meric-Bernstam F. Akcakanat A, et al. Biochem Biophys Res Commun. 2007 Oct 19;362(2):330-3. doi: 10.1016/j.bbrc.2007.07.151. Epub 2007 Aug 8. Biochem Biophys Res Commun. 2007. PMID: 17707343 Free PMC article.

5

Metformin: a therapeutic opportunity in breast cancer.

Gonzalez-Angulo AM, Meric-Bernstam F. Gonzalez-Angulo AM, et al. Clin Cancer Res. 2010 Mar 15;16(6):1695-700. doi: 10.1158/1078-0432.CCR-09-1805. Epub 2010 Mar 9. Clin Cancer Res. 2010. PMID: 20215559 Free PMC article. Review.

6

Regulation and localization of ribosomal protein S6 kinase 1 isoforms.

Kim D, Akcakanat A, Singh G, Sharma C, Meric-Bernstam F. Kim D, et al. Growth Factors. 2009 Feb;27(1):12-21. doi: 10.1080/08977190802556986. Growth Factors. 2009. PMID: 19085255

7

Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases.

Akcakanat A, Sahin A, Shaye AN, Velasco MA, Meric-Bernstam F. Akcakanat A, et al. Cancer. 2008 Jun;112(11):2352-8. doi: 10.1002/cncr.23456. Cancer. 2008. PMID: 18386830 Free PMC article.

8

The rapamycin-regulated gene expression signature determines prognosis for breast cancer.

Akcakanat A, Zhang L, Tsavachidis S, Meric-Bernstam F. Akcakanat A, et al. Mol Cancer. 2009 Sep 24;8:75. doi: 10.1186/1476-4598-8-75. Mol Cancer. 2009. PMID: 19778445 Free PMC article.

9

PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.

Meric-Bernstam F, Akcakanat A, Chen H, Do KA, Sangai T, Adkins F, Gonzalez-Angulo AM, Rashid A, Crosby K, Dong M, Phan AT, Wolff RA, Gupta S, Mills GB, Yao J. Meric-Bernstam F, et al. Clin Cancer Res. 2012 Mar 15;18(6):1777-89. doi: 10.1158/1078-0432.CCR-11-2123. Clin Cancer Res. 2012. PMID: 22422409 Free PMC article.

10

Targeting PI3K/mTOR signaling in cancer.

Emerling BM, Akcakanat A. Emerling BM, et al. Cancer Res. 2011 Dec 15;71(24):7351-9. doi: 10.1158/0008-5472.CAN-11-1699. Epub 2011 Oct 10. Cancer Res. 2011. PMID: 21987725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year